Health & Medicine
Manchester’s ‘first step’ to perfect drug combinations
24 Oct 2011
Scientists at The University of Manchester have discovered a way of speeding up the creation of perfect drug combinations, which could help patients recovering from critical health problems such as stroke, heart attacks and cancer.
Virtual reality helps treat social anxiety
24 Oct 2011
Early origins of chronic mid-life diseases: Low birth weight and poverty have long-term effects
22 Oct 2011
Genetically influenced responses to alcohol affect brain activation
By By Debra Kain | 19 Oct 2011
Antiviral drugs may slow Alzheimer’s progression
18 Oct 2011
Antiviral drugs used to target the herpes virus could be effective at slowing the progression of Alzheimer’s disease (AD), shows a new study
Sniffing out the brain's predictive power
15 Oct 2011
Researchers find that the brain smells what it expects rather than what it sniffs
Monitoring how T cells respond to HIV
By Anne Trafton, MIT News Office | 15 Oct 2011
One of the obstacles to developing an effective AIDS vaccine is the difficulty in measuring how well a potential vaccine primes the body to defend itself against HIV.
Inhaler treatment for lung cancer
12 Oct 2011
Safer and more efficient lung cancer treatment through a nebuliser may replace current intravenous delivery
Study identifies earliest stages of Alzheimer's
12 Oct 2011
Light can detect pre-cancerous colon cells
By By Richard Merritt | 11 Oct 2011
This technology could be a non-invasive way for physicians to detect abnormal cells, or dysplasia, which have the potential of turning cancerous
Immune mechanism blocks inflammation generated by oxidative stress
By By Scott LaFee | 07 Oct 2011
Latest articles
Featured articles
.webp)
Artemis II and the economic outlook for lunar infrastructure
By Axel Miller | 01 Apr 2026
Artemis II will test deep-space systems and support future lunar missions, shaping the next phase of the global space economy.
Synthetic diplomacy: The $50 billion mirage and the new era of market-moving deepfakes
By Cygnus | 30 Mar 2026
Synthetic diplomacy shows how deepfakes could trigger market volatility, highlighting the growing need for verification in global financial systems.
AI war shifts gears: chips, drones reshape global power
By Cygnus | 27 Mar 2026
AI competition is shifting as chips, drones and supply chains reshape global power, impacting tech, defense and business strategies.
Trump’s Iran strike delay lifts markets, but risks remain elevated
By Axel Miller | 24 Mar 2026
Trump’s Iran strike delay eased market fears, sending oil lower and lifting Sensex. Risks remain as geopolitical tensions continue.
The rise of the ‘ghost executive’: how autonomous AI agents are entering the C-suite
By Cygnus | 17 Mar 2026
Autonomous AI agents are influencing business decisions and reshaping leadership structures as companies adopt agentic AI systems in 2026.
The sky is closing: The end of the global crossroads
By Axel Miller | 16 Mar 2026
Middle East airspace disruptions are forcing airlines to reroute global flights, raising costs and reshaping aviation networks in 2026.
Living in the “New Gulf”: how conflict is reshaping cities and infrastructure
By Cygnus | 16 Mar 2026
Gulf states are redesigning infrastructure, air defenses and aviation networks as regional tensions reshape urban resilience strategies.
The Petro-Tech Pivot: Why Your Next Phone Is Built on Shifting Sands
By Cygnus | 12 Mar 2026
Rising crude prices are reshaping electronics manufacturing as petrochemical costs drive pressure across the global tech supply chain.
Hardened compute: The rise of the data bunker
By Axel Miller | 11 Mar 2026
Explore how AI demand and geopolitical risk are driving investment in fortified data centers worldwide.
